Pharmacokinetics, urinary and mammary excretion of ceftriaxone in lactating goats

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 52, Issue 7, 2005, Pages 354-358

  Ismail, M M ^a  

^a Cairo University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CAPRA HIRCUS;

ANTIINFECTIVE AGENT; CEFTRIAXONE;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; FEMALE; GOAT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LACTATION; METABOLISM; PHYSIOLOGY; PREGNANCY; UDDER; URINE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CEFTRIAXONE; FEMALE; GOATS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LACTATION; MAMMARY GLANDS, ANIMAL; PREGNANCY;

EID: 26944489284     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2005.00744.x     Document Type: Article

References (38)

1. Baggot, J. D., 1978: Some aspects of clinical pharmacokinetics in veterinary medicine. J. Vet. Pharmacol. Ther. 1, 5-18.
2. Bennet, J. V., J. L. Brodie, E. J. Benner, and W. M. M. Kirby, 1966: Simplified accurate method for antibiotic assay of clinical specimens. Appl. Microbiol. 14, 170-177.
3. Bergeron, M. G., 1992: What preclinical data are needed to justify once-daily therapy. J. Clin. Pharmacol. 32, 698-705.
4. Bergonier, D., R. Rupp, G. Lagriffoul, and X. Berthelot, 2003: Mastitis of dairy small animals. J. Dairy Sci. 34, 689-716.
5. Blood, D. C., J. A. Handerson, and O. M. Radostits, 1979: Veterinary Medicine. p. 364. Lea and Febiger, Philadelphia, PA.
6. Cavalier, A., D. Leveque, J. D. Peter, J. Salmon, H. El Khalil, Y. Salmon, P. Nobelis, J. Geiserts, H. Monteil, and F. Jehl, 1997: Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs. Antimicrob. Agents Chemother. 41, 2029-2032.
7. Craig, E., 1993: Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimen. Eur. J. Clin. Microbiol. Infect. Dis. 12, 6-8.
8. Craig, A. W., and B. Suh, 1980: Methods for determination of protein binding. In: Lorian, V. (ed.), Antibiotics in Laboratory Medicine, pp. 265-297. Williams and Wilkins, Baltimore, MD.
9. Delsignore, R., C. M. Baroni, G. Crotti, F. Mineo, U. Butturini, V. Ascalone, and M. Cisternino, 1983: Absolute bioavailability of ceftriaxone after intramuscular administration to healthy volunteers. Chemotherapy 29, 157-162.
10. East, N. E., E. F. Birnie, and T. B. Farver, 1987: Risk factors associated with mastitis in dairy goats. Am. J. Vet. Res. 48, 776-779.
11. Foschino, R., A. Invernizzi, R. Barucco, and K. Stradiotto, 2002: Microbial composition, including the incidence of pathogens of goats milk from Bergamo region of Italy during a lactation year. J. Dairy Sci. 69, 213-225.
12. Gibaldi, M., and D. Perrier, 1982: Non Compartmental Analysis Based on Statistical Moment Theory in Pharmacokinetics. Marcel Dekker Inc., New York, NY.
13. Gnann, J. R., E. Goetter, M. Elliott, and G. Cobbs, 1982: Ceftriaxone: in vitro studies and clinical evaluation. Antimicrob. Agents Chemother. 22, 1-9.
14. Guerrini, V. H., L. J. Filippich, and G. R. Cao, 1985: Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep. J. Vet. Pharmacol. Ther. 8, 120-127.
15. Harold, C. N., 1985: Relation of structural properties of beta lactam antibiotics to antibacterial activity. Am. J. Med. 79, 2-13.
16. Hidefumi, M., M. Komiya, C. Ikeda, and A. Tachibana, 1984: Comparative pharmacokinetics of YM-13115, ceftriaxone and ceftazidime in rats, dogs and rhesus monkeys. Antimicrob. Agents Chemother. 26, 204-207.
17. Manser, P. A., 1986: Prevalence, causes and laboratory diagnosis of subclinical mastitis in the goat. Vet. Rec. 118, 552-554.
18. McNamara, P. J., K. Stoeckel, and W. H. Ziegler, 1982: Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. Eur. J. Clin. Pharmacol. 22, 71-75.
19. Patel, I. H., S. Chen, and M. Parsonnet, 1981: Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents Chemother. 20, 634-641.
20. Pickup, M. E., H. A. Bird, J. R. Lowe, L. Lees, and V. Wright, 1981: A pharmacokinetic and tolerance study of RO13-9904 a new cephalosporin antibiotic. Br. J. Clin. Pharmacol. 12, 111-115.
21. Pollock, A. A., P. E. Tee, I. H. Patel, J. Spicehandler, M. S. Simberkoff, and J. J. Rahal, 1982: Pharmacokinetic of ceftriaxone in normal adults. Antimicrob. Agents Chemother. 22, 816-823.
22. Popick, A. C., W. G. Crouthamel, and T. Berersky, 1987: Plasma protein binding of ceftriaxone. Xenobiotica 17, 1139-1145.
23. Poutrel, B., 1984: Udder infection of goats by coagulase-negative staphylococci. Vet. Microbiol. 9, 131-137.
24. Prescott, J. F., J. D. Baggot, and B. D. Walker, 2000: Antimicrobial Therapy in Veterinary Medicine. Iowa State University Press, Ames, IA.
25. Ringger, N. C., E. G. Pearson, R. Gronwall, and S. J. Kohlepp, 1996: Pharmacokinetics of ceftriaxone in healthy horses. Equine Vet. J. 28, 476-479.
26. Ringger, N. C., M. P. Brown, S. J. Kohlepp, R. Gronwall, and K. Merritt, 1998: Pharmacokinetics of ceftriaxone in neonatal foals. Equine Vet. J. 30, 163-165.
27. Rolf, R., and S. Finegold, 1982: Comparative in vitro activity of ceftriaxone against anaerobic bacteria. Antimicrob. Agents Chemother. 22, 338-341.
28. Scheld, W. M., H. Rocha, M. A. Sande, and J. P. Bryan, 1984: Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am. J. Med. 77, 42-49.
29. Seddon, M., R. Wise, A. P. Gillette, and R. Livingston, 1980: Pharmacokinetics of RO13-9904, a broad spectrum cephalosporin. Antimicrob. Agents Chemother. 18, 240-242.
30. Singh, M., M. A. Chaudhary, J. N. Yadava, and S. C. Sanyal, 1992: The spectrum of antibiotic resistance in human and veterinary isolates of Escherichia coli collected from 1984-86 in northern India. J. Antimicrob. Chemother. 29, 159-168.
31. Snedecor, G. W., and W. G. Cochran, 1976: Statistical Methods. Iowa State University Press, Ames, IA.
32. Soback, S., and G. Ziv, 1988: Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly in calves. Am. J. Vet. Res. 49, 535-538.
33. Stoeckel, K., P. J. McNamara, R. Brandt, H. N. Plozza, and W. H. Ziegler, 1981: Effects of concentration dependent plasma protein binding on ceftriaxone kinetics. Clin. Pharmacol. Ther. 29, 650-657.
34. Tozer, T. N., 1981: Concepts basic to pharmacokinetic. Pharmacol. Ther. 12, 109-131.
35. Verheijden, J. H., A. S. Van Miert, A. J. Schotman, and C. T. Van Duin, 1983: Pathophysiological aspects of E. coli mastitis in ruminants. Vet. Res. Commun. 7, 229-236.
36. Waxam, D. J., and J. L. Strominger, 1982: Chemistry and Biology of Beta Lactam Antibiotics. New York Academic Press, New York, NY.
37. Wise, R., 1985: The relevance of pharmacokinetics to in vitro models: protein binding-does it matter. J. Antimicrob. Chemother. 15, 77-83.
38. Yamaoka, K., Y. Tanigawara, and T. T. Nakagawa, 1978: Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6, 165-175.